Please enable JavaScript to continue using this application.

Compare $CUE vs $PEPG | Chartloom

Compare

$CUE vs $PEPG

Cue Biopharma Inc · PepGen Inc

CUE

Cue Biopharma Inc

PEPG

PepGen Inc

Compare $CUE vs $PEPG

Comparing Cue Biopharma Inc and PepGen Inc

CUECue Biopharma Inc

PEPGPepGen Inc

CUECue Biopharma Inc

Market cap

$112M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

354.4%

YTD performance

173.6%

52W performance

7.5%

FCF yield

-44.8%

PEPGPepGen Inc

Market cap

$181M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-63.5%

52W performance

-46.2%

FCF yield

-38.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CUE

PEPG

Detailed metrics comparison

CUE

Cue Biopharma Inc

PEPG

PepGen Inc

Market Cap

CUE$112M

PEPG$181M

Enterprise Value

CUE$95M

PEPG$158M

Price

CUE$27.66

PEPG$2.62

P/E Ratio

CUEN/A

PEPGN/A

P/S Ratio

CUE2.98x

PEPG0.00x

EV/Sales

CUE2.51x

PEPG0.00x

EV/EBITDA

CUE0.00x

PEPG0.00x

P/B Ratio

CUE80.41x

PEPG1.32x

P/FCF Ratio

CUEN/A

PEPGN/A

EV/FCF

CUE-1.89x

PEPG-2.28x

PEG Ratio

CUEN/A

PEPGN/A

Forward P/E (NTM)

CUEN/A

PEPGN/A

Forward P/S (NTM)

CUEN/A

PEPGN/A

Revenue (TTM)

CUE$38M

PEPG$0

Revenue Growth (YoY)

CUE354.4%

PEPGN/A

Forward Rev Growth

CUE-38.2%

PEPG408.5%

Gross Margin (TTM)

CUE0.0%

PEPG0.0%

Operating Margin (TTM)

CUE0.0%

PEPG0.0%

EBITDA Margin (TTM)

CUE-258.4%

PEPG0.0%

Net Margin (TTM)

CUE-435.8%

PEPG0.0%

FCF Margin (TTM)

CUE-133.2%

PEPGN/A

Net Income (TTM)

CUE$-164M

PEPG$-72M

FCF (TTM)

CUE$-50M

PEPG$-69M

EPS (TTM)

CUE-$25.88

PEPG-$1.04

ROE (TTM)

CUE-103219.0%

PEPG-5101.0%

ROA (TTM)

CUE-48467.0%

PEPG-4349.0%

ROIC (TTM)

CUE-100612.0%

PEPG-5101.0%

Cash

CUE$17M

PEPG$23M

Debt

CUE$0

PEPG$0

Net Cash/Debt

CUE$17M

PEPG$23M

Current Ratio (TTM)

CUE1.25x

PEPG13.36x

Quick Ratio (TTM)

CUE1.16x

PEPG13.02x

Debt/Equity (TTM)

CUE0.00x

PEPG0.00x

Debt/Assets (TTM)

CUE0.0%

PEPG0.0%

Interest Coverage (TTM)

CUEN/A

PEPGN/A

Net Debt/EBITDA (TTM)

CUE0.00x

PEPG0.00x

Beta

CUE2.84

PEPG2.00

52W Performance

CUE7.5%

PEPG-46.2%

YTD Performance

CUE173.6%

PEPG-63.5%

% from 52W High

CUE-39.2%

PEPG-66.4%

% from 52W Low

CUE456.4%

PEPG100.0%

Asset Turnover (TTM)

CUE1.11x

PEPG0.00x

FCF Yield (TTM)

CUE-44.8%

PEPG-38.3%

Earnings Yield (TTM)

CUE-146.5%

PEPG-39.7%

Dividend Yield (TTM)

CUEN/A

PEPGN/A

Rule of 40

CUE221.1

PEPG0.0

EV/GP/RG

CUEN/A

PEPGN/A

Ticker research

View CUE research View PEPG research

Metric	CUE Cue Biopharma Inc	PEPG PepGen Inc
Market & Valuation
Market Cap	$112M	$181M
Enterprise Value	$95M	$158M
Price	$27.66	$2.62
P/E Ratio	N/A	N/A
P/S Ratio	2.98x	0.00x
EV/Sales	2.51x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	80.41x	1.32x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.89x	-2.28x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$38M	$0
Revenue Growth (YoY)	354.4%	N/A
Forward Rev Growth	-38.2%	408.5%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-258.4%	0.0%
Net Margin (TTM)	-435.8%	0.0%
FCF Margin (TTM)	-133.2%	N/A
Net Income (TTM)	$-164M	$-72M
FCF (TTM)	$-50M	$-69M
EPS (TTM)	-$25.88	-$1.04
ROE (TTM)	-103219.0%	-5101.0%
ROA (TTM)	-48467.0%	-4349.0%
ROIC (TTM)	-100612.0%	-5101.0%
Financial Health
Cash	$17M	$23M
Debt	$0	$0
Net Cash/Debt	$17M	$23M
Current Ratio (TTM)	1.25x	13.36x
Quick Ratio (TTM)	1.16x	13.02x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.84	2.00
52W Performance	7.5%	-46.2%
YTD Performance	173.6%	-63.5%
% from 52W High	-39.2%	-66.4%
% from 52W Low	456.4%	100.0%
Efficiency & Yields
Asset Turnover (TTM)	1.11x	0.00x
FCF Yield (TTM)	-44.8%	-38.3%
Earnings Yield (TTM)	-146.5%	-39.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	221.1	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CUE research	View PEPG research

Valuation

P/S Ratio

PEPG

0.00x

CUE

2.98x

EV/FCF

PEPG

-2.28x

CUE

-1.89x

Growth & revenue

Revenue Growth TTM

CUE

354.4%

Forward Revenue Growth

PEPG

408.5%

CUE

-38.2%

Profitability & performance

Gross Margin

CUE

0.0%

PEPG

0.0%

ROE

PEPG

-5101.0%

CUE

-103219.0%

FCF Yield %

PEPG

-38.3%

CUE

-44.8%

52-Week Performance

CUE

7.5%

PEPG

-46.2%

Detailed metrics comparison

CUE

Cue Biopharma Inc

PEPG

PepGen Inc

Market Cap

CUE$112M

PEPG$181M

Enterprise Value

CUE$95M

PEPG$158M

Price

CUE$27.66

PEPG$2.62

P/E Ratio

CUEN/A

PEPGN/A

P/S Ratio

CUE2.98x

PEPG0.00x

EV/Sales

CUE2.51x

PEPG0.00x

EV/EBITDA

CUE0.00x

PEPG0.00x

P/B Ratio

CUE80.41x

PEPG1.32x

P/FCF Ratio

CUEN/A

PEPGN/A

EV/FCF

CUE-1.89x

PEPG-2.28x

PEG Ratio

CUEN/A

PEPGN/A

Forward P/E (NTM)

CUEN/A

PEPGN/A

Forward P/S (NTM)

CUEN/A

PEPGN/A

Revenue (TTM)

CUE$38M

PEPG$0

Revenue Growth (YoY)

CUE354.4%

PEPGN/A

Forward Rev Growth

CUE-38.2%

PEPG408.5%

Gross Margin (TTM)

CUE0.0%

PEPG0.0%

Operating Margin (TTM)

CUE0.0%

PEPG0.0%

EBITDA Margin (TTM)

CUE-258.4%

PEPG0.0%

Net Margin (TTM)

CUE-435.8%

PEPG0.0%

FCF Margin (TTM)

CUE-133.2%

PEPGN/A

Net Income (TTM)

CUE$-164M

PEPG$-72M

FCF (TTM)

CUE$-50M

PEPG$-69M

EPS (TTM)

CUE-$25.88

PEPG-$1.04

ROE (TTM)

CUE-103219.0%

PEPG-5101.0%

ROA (TTM)

CUE-48467.0%

PEPG-4349.0%

ROIC (TTM)

CUE-100612.0%

PEPG-5101.0%

Cash

CUE$17M

PEPG$23M

Debt

CUE$0

PEPG$0

Net Cash/Debt

CUE$17M

PEPG$23M

Current Ratio (TTM)

CUE1.25x

PEPG13.36x

Quick Ratio (TTM)

CUE1.16x

PEPG13.02x

Debt/Equity (TTM)

CUE0.00x

PEPG0.00x

Debt/Assets (TTM)

CUE0.0%

PEPG0.0%

Interest Coverage (TTM)

CUEN/A

PEPGN/A

Net Debt/EBITDA (TTM)

CUE0.00x

PEPG0.00x

Beta

CUE2.84

PEPG2.00

52W Performance

CUE7.5%

PEPG-46.2%

YTD Performance

CUE173.6%

PEPG-63.5%

% from 52W High

CUE-39.2%

PEPG-66.4%

% from 52W Low

CUE456.4%

PEPG100.0%

Asset Turnover (TTM)

CUE1.11x

PEPG0.00x

FCF Yield (TTM)

CUE-44.8%

PEPG-38.3%

Earnings Yield (TTM)

CUE-146.5%

PEPG-39.7%

Dividend Yield (TTM)

CUEN/A

PEPGN/A

Rule of 40

CUE221.1

PEPG0.0

EV/GP/RG

CUEN/A

PEPGN/A

Ticker research

View CUE research View PEPG research

Metric	CUE Cue Biopharma Inc	PEPG PepGen Inc
Market & Valuation
Market Cap	$112M	$181M
Enterprise Value	$95M	$158M
Price	$27.66	$2.62
P/E Ratio	N/A	N/A
P/S Ratio	2.98x	0.00x
EV/Sales	2.51x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	80.41x	1.32x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.89x	-2.28x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$38M	$0
Revenue Growth (YoY)	354.4%	N/A
Forward Rev Growth	-38.2%	408.5%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-258.4%	0.0%
Net Margin (TTM)	-435.8%	0.0%
FCF Margin (TTM)	-133.2%	N/A
Net Income (TTM)	$-164M	$-72M
FCF (TTM)	$-50M	$-69M
EPS (TTM)	-$25.88	-$1.04
ROE (TTM)	-103219.0%	-5101.0%
ROA (TTM)	-48467.0%	-4349.0%
ROIC (TTM)	-100612.0%	-5101.0%
Financial Health
Cash	$17M	$23M
Debt	$0	$0
Net Cash/Debt	$17M	$23M
Current Ratio (TTM)	1.25x	13.36x
Quick Ratio (TTM)	1.16x	13.02x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.84	2.00
52W Performance	7.5%	-46.2%
YTD Performance	173.6%	-63.5%
% from 52W High	-39.2%	-66.4%
% from 52W Low	456.4%	100.0%
Efficiency & Yields
Asset Turnover (TTM)	1.11x	0.00x
FCF Yield (TTM)	-44.8%	-38.3%
Earnings Yield (TTM)	-146.5%	-39.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	221.1	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CUE research	View PEPG research